Tue.Nov 14, 2023

article thumbnail

How important are old ECGs in Non-obvious cases of potential OMI?

Dr. Smith's ECG Blog

In the last post, we saw how important old ECGs are in assessing the current ECG in a patient without atypical presentation (in this previous case, the patient had no chest pain, and the apparent inferior OMI did not have reciprocal ST depression in lead aVL). Here is that last post: A 90-something with acute stroke. She has no chest symptoms. What is the diagnosis?

article thumbnail

Pacemaker leads: Atrial and Bi-ventricular

ECG Guru

Click to open: This original artwork was created by Dawn Altman. It is free for your use in a non-commercial setting. For commercial use, contact the artist at Dawn.ECGGuru@gmail.com. All rights reserved.

article thumbnail

Algorithmic fairness in cardiovascular disease risk prediction: overcoming inequalities

Open Heart

The main purpose of prognostic risk prediction models is to identify individuals who are at risk of disease, to enable early intervention. Current prognostic cardiovascular risk prediction models, such as the Systematic COronary Risk Evaluation (SCORE2) and the SCORE2-Older Persons (SCORE2-OP) models, which represent the clinically used gold standard in assessing patient risk for major cardiovascular events in the European Union (EU), generally overlook socioeconomic determinants, leading to dis

article thumbnail

The Devil's Advocate

Society of Thoracic Surgeons - Early Career

Blog The Devil's Advocate pvaldez Tue, 11/14/2023 - 09:27 All Members Surgeon I am an annual contributor to the STS-PAC. Each year, however, as I consider whether to renew my contribution, I find myself in a state of internal debate around one central question. When I contribute to the PAC that is advocating for me, my colleagues and the future of my specialty, am I doing so to the ultimate benefit or detriment of our patients and society more broadly?

Blog 52
article thumbnail

Comorbidities prior to out-of-hospital cardiac arrest and diagnoses at discharge among survivors

Open Heart

Background Out-of-hospital cardiac arrest (OHCA) has a dismal prognosis with overall survival around 10%. Previous studies have shown conflicting results regarding the prevalence and significance of comorbidities in OHCA, as well as the underlying causes. Previously, 80% of sudden cardiac arrest have been attributed to coronary artery disease. We studied comorbidities and discharge diagnoses in OHCA in all of Sweden.

article thumbnail

Medical Image Encryption with the Latest Easy-to-Use Sharing Software

NOVARAD

Medical images, from X-rays to MRIs, have transformed how healthcare professionals diagnose, treat, and understand many conditions. While offering unparalleled convenience, their digital nature also brings forth the challenges of secure storage and transmission. Medical image encryption isn't just a technical term; it's a critical shield ensuring that every pixel of these vital images remains confidential and uncompromised.

52
article thumbnail

Essential hematology for cardiologist

Dr. S. Venkatesan MD

Forget NEJM, Circulation, JACC, for some time. Hope & wish every one of us is aware of a journal called Blood , bringing stunning and dramatic discoveries week after week ,about the most crucial fluid that sustains our life. The journal Blood is published by the American Society of Hematology since 1949. Its impact factor is currently 20.8, celebrating its 75th year of existence.

More Trending

article thumbnail

Role of genetic polymorphisms in clopidogrel response variability: a systematic review

Open Heart

Introduction Clopidogrel is a P2Y 12 inhibitor that has become a mainstay treatment following percutaneous intervention with drug-eluting stent placement to decrease restenosis and its potential complications, including sudden cardiac death and ischaemic strokes in patients with significant vascular disease. Areas covered As a prodrug, the metabolism and efficacy of clopidogrel are contingent on the presence of wild-type CYP450 (CYP2C19) alleles.

article thumbnail

Left bundle branch pacing versus left ventricular septal pacing as a primary procedural endpoint during left bundle branch area pacing: Evaluation of two different implant strategies

Journal of Cardiovascular Electrophysiology

During LBBAP, a strategy aiming to obtain LBB capture in every patient compared to a strategy accepting LVSP as a primary endpoint resulted in comparable implant parameters but higher rates of septal perforation. Patients with proven LBB capture showed a significantly narrow paced QRS but comparable LVEF changes to LVSP. Abstract Introduction Implant procedure features and clinical implications of left bundle branch pacing (LBBP) and left ventricular septal pacing (LVSP) have not been yet fully

article thumbnail

Prognostic value of ECG monitor findings in COVID-19

Open Heart

Aims COVID-19 can cause severe illness and multiorgan dysfunction. Acute myocardial damage has been detected in a significant portion of patients with COVID-19; therefore, several studies have reported that electrocardiographic findings could be used to evaluate the severalty of COVID-19. However, performing standard ECG for each patient hospitalised with COVID-19 can increase the level of exposure to COVID-19 among medical staff.

article thumbnail

Initial clinical experience of atrial fibrillation ablation guided by a cryoballoon?compatible, magnetic?based circular catheter

Journal of Cardiovascular Electrophysiology

Abstract Introduction The circular catheter compatible with current cryoballoon system for atrial fibrillation (AF) ablation is exclusively sensed by impedance-based electro-anatomical mapping (EAM) system, limiting the accuracy of maps. We aim to investigate the feasibility and safety of a magnetic-based circular mapping catheter for AF ablation with cryoballoon.

article thumbnail

Irregular Rhythm and New-Onset Heart Failure

JAMA Cardiology

A man in his 50s with recurrent palpitations, fatigue, and progressive exertion dyspnea had irregular narrow-QRS tachycardia in an incessant, repetitive fashion with heart rates up to 180 beats per minute and occasional short runs of wide-QRS tachycardia on Holter monitoring and 12-lead electrocardiogram. What would you do next?

article thumbnail

Qiliqiangxin: A multifaceted holistic treatment for heart failure or a pharmacological probe for the identification of cardioprotective mechanisms?

European Journal of Heart Failure

The active ingredients in many traditional Chinese medicines are isoprene oligomers with a diterpenoid or triterpenoid structure, which exert cardiovascular effects by signalling through nutrient surplus and nutrient deprivation pathways. Qiliqiangxin (QLQX) is a commercial formulation of 11 different plant ingredients, whose active compounds include astragaloside IV, tanshione IIA, ginsenosides (Rb1, Rg1 and Re) and periplocymarin.

article thumbnail

Effect of Tafamidis on Cardiac Function in Patients With Transthyretin Amyloid Cardiomyopathy

JAMA Cardiology

This post hoc analysis of the randomized Tafamidis in Transthyretin Cardiomyopathy Clinical Trial examines the effect of tafamidis vs placebo on 30-month changes in cardiac function in patients with transthyretin amyloid cardiomyopathy.

article thumbnail

Novel Pan-ERR Agonists Ameliorate Heart Failure Through Enhancing Cardiac Fatty Acid Metabolism and Mitochondrial Function

Circulation

Circulation, Ahead of Print. BACKGROUND:Cardiac metabolic dysfunction is a hallmark of heart failure (HF). Estrogen-related receptors ERRα and ERRγ are essential regulators of cardiac metabolism. Therefore, activation of ERR could be a potential therapeutic intervention for HF. However, in vivo studies demonstrating the potential usefulness of ERR agonist for HF treatment are lacking, because compounds with pharmacokinetics appropriate for in vivo use have not been available.METHODS:Using a stru

article thumbnail

Researcher helps solve 60-year mystery inside heart

Science Daily - Heart Disease

Scientists have solve a 60-year-old mystery about one of the body's most vital organs: the heart.

article thumbnail

Trends in Hypertension Control Among United States Adults: Is NHANES the Outlier?

Hypertension Journal

Hypertension, Volume 80, Issue 12 , Page 2544-2546, December 1, 2023.

article thumbnail

Does Exercise Prevent Cancer?

Dr. Paddy Barrett

Let’s start with the simple fact that a lot of cancer diagnoses are simply down to ‘bad luck’ You can do everything right and still get cancer. This is a somewhat depressing fact, given its leading position as a cause of death. The other leading cause of death, cardiovascular disease, is mostly preventable. Cancer - Less so. Subscribe now But that does not mean you cannot tilt the odds in your favour.

Cancer 52
article thumbnail

The Apples and Oranges of Blood Pressure Variability

Hypertension Journal

Hypertension, Volume 80, Issue 12 , Page 2556-2558, December 1, 2023.

article thumbnail

Effect of Mavacamten in Women Compared With Men With Obstructive Hypertrophic Cardiomyopathy: Insights From EXPLORER-HCM

Circulation

Circulation, Ahead of Print. BACKGROUND:Compared with men, women with hypertrophic cardiomyopathy (HCM) have a higher incidence of heart failure and worse outcomes. We investigated baseline clinical and echocardiographic characteristics and response to mavacamten among women compared with men in the EXPLORER-HCM study (Clinical Study to Evaluate Mavacamten [MYK-461] in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy).METHODS:A prespecified post hoc analysis of sex from the blinde

article thumbnail

Incidence, risk assessment and prevention of sudden cardiac death in cardiomyopathies

European Journal of Heart Failure

Sudden cardiac death in cardiomyoptahies: incidence, risk factors and prevention. AV, atrioventricular; CMR, cardiac magnetic resonance; CRT, cardiac resynchronization therapy; CV, cardiovascular; FLNC, filamin C; GDMT, guideline-directed medical therapy; HCM, hypertrophic cardiomyopathy; HFrEF, heart failure with reduced ejection fraction; ICD, implantable cardioverter-defibrillator; LGE, late gadolinium enhancement; LMNA, lamin A/C; LV, left ventricular; LVEF, left ventricular ejection fractio